Abstract
Background
Basolateral K+ channels hyperpolarize colonocytes to ensure Na+ (and thus water) absorption. Small conductance basolateral (KCNQ1/KCNE3) K+ channels have never been evaluated in human colon. We therefore evaluated KCNQ1/KCNE3 channels in distal colonic crypts obtained from normal and active ulcerative colitis (UC) patients.
Methods
KCNQ1 and KCNE3 mRNA levels were determined by qPCR, and KCNQ1/KCNE3 channel activity in normal and UC crypts, and the effects of forskolin (activator of adenylate cyclase) and UC-related proinflammatory cytokines on normal crypts, studied by patch clamp recording.
Results
Whereas KCNQ1 and KCNE3 mRNA expression was similar in normal and UC crypts, single 6.8 pS channels were seen in 36% of basolateral patches in normal crypts, and to an even greater extent (74% of patches, P < 0.001) in UC crypts, with two or more channels per patch. Channel activity was 10-fold higher (P < 0.001) in UC crypts, with a greater contribution to basolateral conductance (5.85 ± 0.62 mS cm−2) than in controls (0.28 ± 0.04 mS cm−2, P < 0.001). In control crypts, forskolin and thromboxane A2 stimulated channel activity 30-fold and 10-fold respectively, while PGE2, IL-1β, and LTD4 had no effect.
Conclusions
KCNQ1/KCNE3 channels make only a small contribution to basolateral conductance in normal colonic crypts, with increased channel activity in UC appearing insufficient to prevent colonic cell depolarization in this disease. This supports the proposal that defective Na+ absorption rather than enhanced Cl− secretion, is the dominant pathophysiological mechanism of diarrhea in UC.
Keywords: Human colonic crypts, Ulcerative colitis, KCNQ1/KCNE3 channels, Patch clamp
1. Introduction
Basolateral potassium (K+) channels play a central role in maintaining colonic epithelial cells in a hyperpolarized state, which is a critical requirement for ionic movements across the apical and basolateral membranes. In healthy human colonic epithelium, the basolateral K+ conductance largely reflects intermediate conductance basolateral K+ (IK; KCNN4) channels [1]. In active ulcerative colitis (UC), the marked decrease in IK channel expression/activity (with ensuing cellular depolarization) has been proposed as one of the factors contributing to colonic malabsorption of Na+ (and thus water) in this disease [1]. Indeed, diarrhea, the dominant symptom in UC, largely reflects defective Na+ and water absorption, rather than increased Cl− secretion across the inflamed colonic mucosa [2], [3], [4], [5].
Although IK channels dominate the basolateral K+ conductance in human colon [1]. basolateral membranes of mouse small intestinal and colonic crypt cells also contain small conductance K+ (SK or KCNQ1/KCNE3) channels [6], [7], [8]. However, the possible existence of KCNQ1/KCNE3 channels and their contribution to the basolateral K+ conductance of human colonic crypt cells, has never been explored. KCNQ1 is a K+ channel protein with six transmembrane domains, and interacts physically with the smaller β-subunit KCNE3 protein, which has a single transmembrane domain [9]. KCNE3 changes the biophysical properties of KCNQ1, the KCNQ1/KCNE3 complex forming a constitutively open basolateral K+ channel, which is present in mammalian small intestine and colon, is readily stimulated by cAMP, markedly inhibited by chromanol 293B, and is a prerequisite for cAMP-stimulated electrogenic Cl− secretion, such as that triggered by a variety of intestinal pathogens [9]. The role of KCNQ1/KCNE3 channels appears to be to maintain the Cl− secretory response by recycling K+ entering the cell via the basolateral Na+–K+–2Cl− cotransporter, thus hyperpolarizing the cell while stimulating basolateral Cl− uptake as a prelude to apical Cl− exit via CFTR Cl− channels [9]. However, the transmucosal electrical properties of the colon in active UC are not consistent with electrogenic Cl− secretion [2], [3], nor has Cl− secretion been reported in this disease in previous ion transport studies [2], [10], which raises the possibility that the expression/activity of putative KCNQ1/KCNE3 channels in the inflamed colon might be decreased. The aims of the present study were to identify and characterize KCNQ1/KCNE3 channels in healthy (control) human colon, and then study their activity in patients with active UC.
2. Materials and methods
2.1. Quantitative polymerase chain reaction (qPCR)
Crypts for qPCR were isolated from 5 to 6 sigmoid mucosal biopsies taken during colonoscopic evaluation of patients with functional abdominal pain who were free of inflammatory bowel disease (controls, n = 9), and patients with moderately active UC (n = 7), by Ca2+ chelation [11]. Crypts were pelleted by centrifugation and total RNA extracted using TRI reagent (Sigma) according to the manufacturer's instructions. RNA was quantified by a RiboGreen (Invitrogen, Paisley, UK) assay, using a standard curve constructed with RNA of known concentrations. 1 μg of total RNA was reverse transcribed at 37 °C using Superscript reverse transcriptase (Invitrogen, Paisley, UK) with oligo-(dT)12–18 primers according to the manufacturer's instructions.
cDNA was subsequently used as a template for 40 rounds of PCR with intron-spanning primers specific for human KCNQ1 (sense AGCAGAAGCAGAGGCAGAAG; antisense CTGGGTGACAGCAGAGTGTG, KCNE3 (sense GCAGAGGGAAATGAGACAGG; antisense CAGGGTGGTGGTGGTAAATC) and β-actin (sense AGAAAATCTGGCACCACACC; antisense GGGTGTTGAAGGTCTCAAA), the latter acting as an endogenous reference to allow compensation for small variations in sample concentration. Amplification of DNA products was measured in real-time (Lightcycler, Roche) by incorporating the DNA-binding dye SYBR Green I (Quantitech). Primer efficacy was validated by gel electrophoresis of the PCR reaction, and amplification of single products of the expected molecular weight (KCNQ1 160 bp; KCNE3 119 bp; β-actin 148 bp) confirmed by sequencing (Lark Technologies). Real-time PCR crossing point (Cp) was determined using the ‘second derivative maximum method’ [12]. PCR efficiency (E) was calculated from the slope of the log-linear amplification phase using the LinReg software package [13]. The amounts of KCNQ1 and KCNE3 mRNA relative to β-actin were expressed as ECpβ-actin/ECpchannel [14]. The specificity of RT–PCR products was also routinely confirmed by melting curve analysis.
2.2. Patch clamp recording
Crypts for patch clamp studies were isolated from colonoscopic mucosal biopsies taken during evaluation of consented control patients (n = 34), and patients with moderately active UC (n = 9), by Ca2+ chelation [11]. None of the patients was receiving steroid treatment. Crypts were maintained on ice until required. Crypts were placed on a glass coverslip pre-treated with poly-l-lysine (0.1%) in a perfusion chamber (Warner Instruments), which was mounted on an inverted microscope (Nikon Diaphot). The perfusion chamber solution contained 140 mM NaCl, 4.5 mM KCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 10 mM HEPES, and 5 mM glucose, titrated to pH 7.4 with NaOH. Patch pipettes were fabricated from soda-lime microhematocrit glass using a two-stage puller (Narishige, Model PP-83) and had tip resistances of 2–4 MΩ when filled with a solution containing 145 mM KCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 10 mM HEPES and 5 mM glucose, titrated to pH 7.4 with KOH. After filling with solution, pipettes were subsequently dipped briefly, up to the base of the shank, in silane (Sigmacote, Sigma) to reduce stray capacitance. Patch clamp recordings were obtained in the cell-attached configuration from the basolateral membranes of cells in the mid-third region of crypts. Cell currents were amplified and low-pass filtered at 2 kHz (Axopatch 200B, Axon Instruments), and sampled to computer at 5 kHz via a Digidata 1320A interface (Axon Instruments). Command potentials (Vcom) were applied to the pipette interior and referenced to the bath (ground). Data acquisition and analysis were performed using pClamp 9.0 software (Axon Instruments). Channel activity was measured as N.Po, where Po is the single channel open probability and N is the number of channels in the patch (taken to be the maximum number of open channels during the recording).
Having identified basolateral KCNQ1/KCNE3 channels in crypts from control patients, additional experiments were performed to determine the effect of 10 μM forskolin (an activator of adenylate cyclase, thereby increasing intracellular cAMP concentration), and a variety of inflammatory mediators present at increased concentration in the colonic epithelium of patients with active UC: 100 nM prostaglandin E2 (PGE2), 1 μM thromboxane A2 (TXA2), 10 nM interleukin 1-β (IL-1β), and 1 μM leukotriene D4 [15], [16], [17], [18]. Recordings of KCNQ1/KCNE3 channel activity were made before and 5 min after addition of the agent under study to the bath solution.
2.3. Statistics
Data are given as mean ± SEM, where n corresponds to the number of subjects unless otherwise indicated. Comparison between groups was made using the Wilcoxon Signed Rank test and Mann–Whitney U test for paired and unpaired data, respectively.
3. Results
3.1. Molecular characteristics of KCNQ1/KCNE3 channels in human colon
RT-PCR using specific primers indicated the presence of KCNQ1, KCNE3 and β-actin (as the internal control) in colonic crypt cells from control patients and those with active UC. Agarose gel (1.3%) electrophoresis showed that the single product bands were of the expected size (Fig. 1A), fragment sizes for KCNQ1, KCNE3 and β-actin being 160 bp, 119 bp and 148 bp, respectively. The identity of the products was confirmed by automated sequencing (Lark Technologies). Amplification of KCNQ1, KCNE3 and β-actin mRNAs was monitored using SYBR Green 1, and during PCR amplification, SYBR green fluorescence increased in a log-linear fashion once it was above the threshold for detection by the lightcycler (Fig. 1B). Specificity of the RT-PCR products was also confirmed by melting curve analysis, the rate of release of the fluorophore during DNA strand separation being greatest at the product-specific melting temperature (Tm), the presence of a single peak indicating the presence of a single product. The measured values of Tm for KCNQ1, KCNE3 and β-actin were 85.1 °C, 77.1 °C and 85.2 °C, respectively (Fig. 1C). There were no significant differences in the expression of KCNQ1 mRNA or KCNE3 mRNA between control patients and those with active UC (Fig. 1D).
3.2. Electrophysiological characteristics of KCNQ1/KCNE3 channels in human colon
KCNQ1/KCNE3 channel activity was studied in cell-attached patches of the basolateral membrane of cells in the mid-crypt region of crypts obtained from control patients (n = 34), channel activity being observed in 36% of patches. Representative recordings, together with the corresponding current–voltage (I/Vcom) relationship, are shown in Fig. 2A and B, respectively. Patches usually contained one channel (Fig. 2A), with a slope conductance of 6.8 ± 0.5 pS. This value was of the same order as those obtained for the basolateral KCNQ1/KCNE3 channel in rat colon crypt cells (∼3 pS) [19], and the human KCNQ1/KCNE3 channel (4.5 pS) expressed in Xenopus oocytes [20]. By contrast, KCNQ1/KCNE3 channel activity was observed in 74% of patches in crypts obtained from patients with active UC (n = 9), the difference in channel prevalence between the two groups of patients being significant (P < 0.001). Furthermore, patches from UC patients usually contained two or more channels (Fig. 3B), and overall KCNQ1/KCNE3 channel activity (N.Po) was 10-fold greater in UC patients (1.13 ± 0.28) than in control patients (0.11 ± 0.02, P < 0.001).
The physiological importance of the basolateral K+ conductance of epithelial cells in general lies in its role in allowing K+ ions to recycle across the membrane, thus keeping cells hyperpolarized, a prerequisite for vectorial ion transport. Based on the assumption that IK channels account for most of the basolateral K+ conductance in normal human colonic crypt cells, we previously reported that the decreases in basolateral IK channel expression and activity seen in active UC lead to a ∼75% decrease in basolateral K+ conductance [1]. In the present study, we calculated basolateral membrane conductance due to KCNQ1/KCNE3 channels (GSK) in control and UC patients as:
with N.Po taken as the average N.Po of all patches obtained from an individual patient rather than the N.Po of a single patch, a single channel conductance (g) of 7 pS, and an assumed patch area of 1 μm2. The calculated value of GSK in patients with active UC (5.85 ± 0.62 mS cm−2) was significantly greater than the value in control patients (0.28 ± 0.04 mS cm−2, P < 0.001).
3.3. Activation of KCNQ1/KCNE3 channels in human colon
In cell-attached patches using crypts from control patients, addition of 10 μM forskolin to the bath solution resulted in the stimulation of basolateral KCNQ1/KCNE3 channels, N.Po increasing from 0.01 ± 0.003 to 0.32 ± 0.08 (P < 0.005, n = 8), and a representative experiment is shown in Fig. 4A. The addition of 1 μM TXA2 also stimulated KCNQ1/KCNE3 channel activity, N.Po increasing from 0.02 ± 0.01 to 0.18 ± 0.07 (P < 0.05, n = 5), and a representative experiment is shown in Fig. 4B. However, neither 100 nM PGE2, 10 nM IL-1β, nor 1 μM LTD4 had any significant effect on KCNQ1/KCNE3 channel activity (0.08 ± 0.05 versus 0.24 ± 0.19, P = 0.4, n = 6; 0.12 ± 0.11 versus 0.28 ± 0.09, P = 0.25, n = 5; and 0.25 ± 0.18 versus 0.25 ± 0.08, P = 0.99, n = 4, respectively).
4. Discussion
The present study shows for the first time that (i) both KCNQ1 mRNA and KCNE3 mRNA are present in control human colonic epithelial cells, (ii) low basal levels of KCNQ1/KCNE3 channel activity are present in the basolateral membranes of these cells, and (iii) these low basal levels of KCNQ1/KCNE3 channel activity are markedly stimulated by forskolin-induced cAMP-dependent phosphorylation. We found the single channel conductance of basolateral KCNQ1/KCNE3 channels in control human colon (6.8 ± 0.5 pS) to be similar to that of human KCNQ1/KCNE3 channels expressed in Xenopus oocytes (4.5 pS) [20]. Based on the findings that basolateral KCNQ1/KCNE3 channels (i) co-exist with apical Cl− (CFTR) channels in intestinal crypt cells [21], (ii) are stimulated by cAMP [8], and (iii) inhibited by chromanol 293B (resulting in the inhibition of electrogenic Cl− secretion) [8], it has become clear that these K+ channels play a critical role during cAMP-activated Cl− secretion, recycling K+ ions across the basolateral membrane to maintain a favourable electrical gradient for apical Cl− exit, thus making them a prime target for novel anti-diarrheal drugs.
Although we observed an increase in basolateral KCNQ1/KCNE3 channel activity, and what appeared to be an increase in the number (and presumably density) of channels per patch in cells from UC patients compared with controls, the levels of KCNQ1 mRNA and KCNE3 mRNA were similar in the two groups. This suggests that the apparent increase in KCNQ1/KCNE3 channel density reflects a post-transcriptional event, possibly increased sorting of channel protein(s) to the basolateral membrane. This would be in broad agreement with our previous finding of uniform expression of high conductance apical potassium (BK; KCNMA1) channels along the entire surface-crypt cell axis in UC patients, whereas they are largely restricted to surface cells and cells in the upper 20% of crypts in control human colon [22]. Why KCNQ1/KCNE3 channel expression (or for that matter BK channel expression) should be increased in human UC is unclear, but it is interesting that butyrate, a key energy source for colonocytes, suppresses NKCC1 (basolateral Na+-K+–2Cl− cotransporter isoform-1) gene expression in human colon-derived HT29 cells [23]. Thus, it is conceivable that reduced oxidation of butyrate by colonic epithelial cells, as occurs in UC [24], might result in upregulation of KCNQ1/KCNE3 and/or BK channels in this disease. In any event, our finding of increased basolateral KCNQ1/KCNE3 channel activity in active UC is in marked contrast to our previously reported observation of substantial decreases in basolateral IK channel expression and activity in these patients [1]. We have proposed that these changes may explain the cell depolarization seen in active UC, thereby decreasing the electrical driving force for electrogenic Na+ absorption (and as a consequence, Cl− and water absorption) across the inflamed mucosa [1]. Despite the fact that the increase in basolateral KCNQ1/KCNE3 channel activity in UC patients resulted in a significantly greater calculated basolateral membrane conductance (GSK, 5.85 ± 0.62 mS cm−2) compared with controls (0.28 ± 0.04 mS cm−2, P < 0.001), this increase in GSK was too small to fully compensate for the ∼17 mS cm−2 decrease in basolateral membrane conductance secondary to reduced IK channel expression and activity in UC patients [1]. Thus, while the increase in basolateral KCNQ1/KCNE3 channel activity in UC patients could be construed as an attempt to maintain colonocytes in a state of hyperpolarization, this clearly does not occur, as colonocytes in UC patients have been shown to be significantly depolarized in studies using intracellular microelectrodes [3].
Our studies using crypts from control patients showed that increasing intracellular cAMP (using exogenous forskolin) elicited a 30-fold rise in basolateral KCNQ1/KCNE3 channel activity. This observation is consistent with the chromanol 293B-inhibitable, cAMP-stimulated Cl− secretion previously demonstrated in mouse colon [25], highlighting the channel's role in basolateral K+ recycling in order to maintain a favourable electrical gradient for apical Cl− exit. PGE2 is an eicosanoid inflammatory mediator produced in leukocytes by the oxidation of arachidonic acid through arachidonate 5-lipoxygenase activity, and its intramucosal levels are substantially increased in UC [16]. Since the ion transport effects of PGE2 are at least partly mediated by cAMP [26], [27], the higher levels of KCNQ1/KCNE3 channel activity seen in UC patients may have reflected a cAMP-dependent stimulatory effect of PGE2. However, for reasons that are unclear, 100 nM PGE2 failed to activate KCNQ1/KCNE3 channel activity in control crypts. We also studied the effect of TXA2, another eicosanoid inflammatory mediator present at increased concentrations in the inflamed colonic mucosa in active UC, and capable of stimulating Cl− secretion in normal rat colon [16]. Unlike PGE2, TXA2 elicited a 10-fold increase in KCNQ1/KCNE3 channel activity in control crypts, which suggests a regulatory link between TXA2 receptors and KCNQ1/KCNE3 channels. TxA2 has been shown to increase intracellular Ca2+ in platelets [28], and thus its stimulatory effect on KCNQ1/KCNE3 channels in human colonic crypts may also be Ca2+-mediated, since carbachol (a Ca2+-mediated cholinergic agonist) activated KCNQ1/KCNE3 channels during its stimulation of Cl− secretion in mouse colon [29]. Intracellular Ca2+ regulates KCNQ1 via calmodulin and other Ca2+-sensor proteins [30]. Interestingly, the antidiarrheal drug loperamide markedly inhibits TxA2-induced Cl− secretion in normal rat distal colon without affecting the TxA2-induced increase in intracellular Ca2+ concentration [31]. Furthermore, the specific calmodulin inhibitor W-7 has an even greater inhibitory effect on TxA2-induced Cl− secretion, which suggests that loperamide's antisecretory effect involves blockade of the calmodulin system [31]. However, even if PGE2 and TXA2 stimulate KCNQ1/KCNE3 channel activity in active UC, this is not accompanied by an overall Cl− secretory response, as net colonic Cl− secretion does not occur in patients with this disease [2], [3]. By contrast, the proinflammatory mediators IL-1β (which originates from helper CD4 T lymphocytes, monocytes, macrophages and endothelial cells), and LTD4 (another eicosanoid inflammatory mediator), both of which stimulate Cl− secretion in non-inflamed mammalian colon [15], [17], failed to stimulate KCNQ1/KCNE3 channel activity in control crypts, due to either the acute nature of our experiments, or the non-involvement of KCNQ1/KCNE3 channels in the Cl−-secretory effects of IL-1β and LTD4.
In summary, we have shown for the first time that cAMP-stimulated KCNQ1/KCNE3 channels reside in the basolateral membrane of healthy human colonic crypt cells, and that their activity is increased in active UC. This builds on our previous studies, which indicated an expanded distribution of apical BK channels, with the virtual disappearance of basolateral IK channels, along the surface-crypt axis in these patients [1], [22]. Thus, it is clear that different types of K+ channel, each with a crucial role to play in ion transport across healthy human colon, undergo profound changes in expression and activity in active UC. A more detailed picture is therefore emerging about the pathophysiology of diarrhoea in this disease [1]. Given the recent evidence in human colon for partitioning of Cl− and K+ secretory pathways between colonocytes and goblet cells respectively [32], further studies are required to map different types of K+ channel along the surface-crypt axis in healthy and inflamed colon, and to identify the intracellular mechanisms that modify K+ channel expression during the inflammatory process.
Conflict of interest
None of the authors have any actual or potential conflicts of interest.
Author contribution statement
JEL, MH and GIS conceived the experiments and analysed the data. AA-H, JEL and QA carried out the experiments, and acquired and analysed the data. GIS and MH were involved in writing the paper. All authors approved the submitted version of the paper.
Acknowledgement
This study was supported by grants from the Wellcome Trust (grant number 066314) and Yorkshire Cancer Research (grant number L309).
Footnotes
Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.bbrc.2015.12.086.
Appendix A. Supplementary data
The following is the supplementary data related to this article:
References
- 1.Al-Hazza A., Linley J.E., Aziz Q. Potential role of reduced basolateral potassium (IKCa3.1) channel expression in the pathogenesis of diarrhoea in ulcerative colitis. J. Pathol. 2012;226:463–470. doi: 10.1002/path.2994. [DOI] [PubMed] [Google Scholar]
- 2.Sandle G.I., Hayslett J.P., Binder H.J. Effect of glucocorticoids on rectal transport in normal subjects and patients with ulcerative colitis. Gut. 1986;27:309–316. doi: 10.1136/gut.27.3.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sandle G.I., Higgs N., Crowe P. Cellular basis for defective electrolyte transport in inflamed human colon. Gastroenterology. 1990;99:97–105. doi: 10.1016/0016-5085(90)91235-x. [DOI] [PubMed] [Google Scholar]
- 4.Amasheh S., Barmeyer C., Koch C.S. Cytokine-dependent transcriptional down regulation of epithelial sodium channel in ulcerative colitis. Gastroenterology. 2004;126:1711–1720. doi: 10.1053/j.gastro.2004.03.010. [DOI] [PubMed] [Google Scholar]
- 5.Greig E.R., Boot-Handford R.P., Mani V. Decreased expression of apical Na+ channels and basolateral Na+,K+-ATPase in ulcerative colitis. J. Pathol. 2004;204:84–92. doi: 10.1002/path.1613. [DOI] [PubMed] [Google Scholar]
- 6.Dedek K., Waldegger S. Colocalization of KCNQ1/KCNE channel subunits in the mouse gastrointestinal tract. Pflügers Arch. 2001;442:896–902. doi: 10.1007/s004240100609. [DOI] [PubMed] [Google Scholar]
- 7.Demolombe S., Franco D., de Boer P. Differential expression of KvLQT1 and its regulator IsK in mouse epithelia. Am. J. Physiol. Cell Physiol. 2001;280:C359–C372. doi: 10.1152/ajpcell.2001.280.2.C359. [DOI] [PubMed] [Google Scholar]
- 8.Warth R., Alzamora M.G., Kim J.K. The role of KCNQ1/KCNE1 K+ channels in intestinal and pancreas: lessons from the KCNE1 knockout mouse. Pflügers Arch. 2002;443:822–828. doi: 10.1007/s00424-001-0751-3. [DOI] [PubMed] [Google Scholar]
- 9.Schroeder B.C., Waldegger S., Fehr S. A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature. 2000;403:196–199. doi: 10.1038/35003200. [DOI] [PubMed] [Google Scholar]
- 10.Hawker P.C., McKay J.S., Turnberg L.A. Electrolyte transport across colonic mucosa from patients with inflammatory bowel disease. Gastroenterology. 1980;79:508–511. [PubMed] [Google Scholar]
- 11.Bowley K.A., Morton M.J., Hunter M. Non-genomic regulation of intermediate conductance potassium channels by aldosterone inhuman colonic crypt cells. Gut. 2003;52:854–860. doi: 10.1136/gut.52.6.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Van L.T., Paquet N., Calvo E. Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques. 2005;38:287–293. doi: 10.2144/05382RR05. [DOI] [PubMed] [Google Scholar]
- 13.Ramakers C., Ruijter J.M., Deprez R.H. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 2003;339:62–66. doi: 10.1016/s0304-3940(02)01423-4. [DOI] [PubMed] [Google Scholar]
- 14.Fountain S.J., Cheong A., Flemming R. Functional upregulation of KCNA gene family expression in murine mesenteric resistance artery smooth muscle. J. Physiol. 2004;556:29–42. doi: 10.1113/jphysiol.2003.058594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wardle T.D., Hall L., Turnberg L.A. Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion. Gut. 1993;34:503–508. doi: 10.1136/gut.34.4.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ligumsky M., Karmeli F., Sharon P. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology. 1981;81:444–449. [PubMed] [Google Scholar]
- 17.Wardle T.D., Turnberg L.A. Potential role for interleukin-1 in the pathophysiology of ulcerative colitis. Clin. Sci. 1994;86:619–626. doi: 10.1042/cs0860619. [DOI] [PubMed] [Google Scholar]
- 18.Wardle T.D., Hall L., Turnberg L.A. Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion. Gut. 1996;38:355–361. doi: 10.1136/gut.38.3.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Warth R., Riedemann N., Bleich M. The cAMP-regulated and 293B-inhibited K+ conductance of rat colonic crypt base cells. Pflügers Arch. 1996;432:81–88. doi: 10.1007/s004240050108. [DOI] [PubMed] [Google Scholar]
- 20.Yang Y., Sigworth F.J. Single-channel properties of IKs potassium channels. J. Gen. Physiol. 1998;112:665–678. doi: 10.1085/jgp.112.6.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Trezíse A.E.O., Buchwald M. In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature. 1991;353:434–437. doi: 10.1038/353434a0. [DOI] [PubMed] [Google Scholar]
- 22.Sandle G.I., Perry M.D., Mathialahan T. Altered cryptal expression of luminal potassium (BK) channels in ulcerative colitis. J. Pathol. 2007;212:66–73. doi: 10.1002/path.2159. [DOI] [PubMed] [Google Scholar]
- 23.Matthews J.B., Hassan I., Meng S. Na-K-2Cl cotransporter gene expression and function during enterocyte differentiation. Modulation of Cl− secretory capacity by butyrate. J. Clin. Invest. 1998;101:b2072–2079. doi: 10.1172/JCI1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Roediger W.E.W. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet. 1989;316(2):712–715. doi: 10.1016/s0140-6736(80)91934-0. [DOI] [PubMed] [Google Scholar]
- 25.Preston P., Wartosch L., Günzel D. Disruption of the K+ channel β-subunit KCNE3 reveals an important role in intestinal and tracheal Cl− transport. J. Biol. Chem. 2010;285:7165–7175. doi: 10.1074/jbc.M109.047829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Sonnenburg W.K., Smith W.L. Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins. J. Biol. Chem. 1988;263:6155–6160. [PubMed] [Google Scholar]
- 27.Noland T.D., Carter C.E., Jacobson H.R. PGE2 regulates cAMP production in cultured rabbit CCD cells: evidence for dual inhibitory mechanisms. Am. J. Physiol. Cell Physiol. 1992;263:C1208–C1215. doi: 10.1152/ajpcell.1992.263.6.C1208. [DOI] [PubMed] [Google Scholar]
- 28.Wacker M.J., Kosloski L.M., Gilbert W.J.R. Inhibition of thromboxane A2-induced arrhythmias and intracellular calcium changes in cardiac myocytes by blockade of the inositol trisphosphate pathway. J. Pharmacol. Exp. Ther. 2009;331:917–924. doi: 10.1124/jpet.109.157677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Matos J.E., Sausbier M., Beranek G. Role of cholinergic-activated KCa1.1 (BK), KCa3.1 (SK4) and KV7.1 (KCNQ1) channels in mouse colonic Cl− secretion. Acta Physiol. 2007;189:251–258. doi: 10.1111/j.1748-1716.2006.01646.x. [DOI] [PubMed] [Google Scholar]
- 30.Inanobe A., Tsuzuki C., Kurachi Y. An epithelial Ca2+-sensor protein is an alternative to calmodulin to compose functional KCNQ1 channels. Cell Physiol. Biochem. 2015;36:1847–1861. doi: 10.1159/000430155. [DOI] [PubMed] [Google Scholar]
- 31.Suzuki T., Sakai H., Ikari A. Inhibition of thromboxane A2-induced Cl− secretion by antidiarrhoea drug loperamide in isolated rat colon. J. Pharmacol. Exp. Ther. 2000;295:233–238. [PubMed] [Google Scholar]
- 32.Linley J.E., Loganathan A., Kopanati S. Evidence that two distinct crypt cell types secrete chloride and potassium in human colon. Gut. 2014;63:472–479. doi: 10.1136/gutjnl-2013-304695. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.